Literature DB >> 20101758

Clodronate liposomes: all sites of injection are not equal.

Nicolas Lanthier, Yves Horsmans, Isabelle A Leclercq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20101758     DOI： 10.1002/hep.23455

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice.

Authors:  Olivia Osborn; Da Young Oh; Joanne McNelis; Manuel Sanchez-Alavez; Saswata Talukdar; Min Lu; Pingping Li; Lucinda Thiede; Hidetaka Morinaga; Jane J Kim; Jan Heinrichsdorff; Sarah Nalbandian; Jachelle M Ofrecio; Miriam Scadeng; Simon Schenk; John Hadcock; Tamas Bartfai; Jerrold M Olefsky
Journal:  J Clin Invest       Date:  2012-06-01       Impact factor: 14.808

2.  Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how?

Authors:  Nicolas Lanthier
Journal:  World J Hepatol       Date:  2015-09-08

3.  Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease.

Authors:  Kouichi Miura; Ekihiro Seki; Hirohide Ohnishi; David A Brenner
Journal:  Gastroenterol Res Pract       Date:  2011-01-17       Impact factor: 2.260

4.  Repeated clodronate-liposome treatment results in neutrophilia and is not effective in limiting obesity-linked metabolic impairments.

Authors:  Jackie E Bader; Reilly T Enos; Kandy T Velázquez; Meredith S Carson; Alex T Sougiannis; Owen P McGuinness; Cory M Robinson; E Angela Murphy
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-21       Impact factor: 5.900
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.